Recombinant SARS-CoV-2 Spike RBD Protein with mFc Tag

Description
Recombinant SARS-CoV-2 Spike RBD Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Arg319-Phe541) of 2019-ncov Spike RBD (Accession #YP_009724390.1) fused with an mFc tag at the C-terminus.

Bio-Activity
Measured by its binding ability in a functional ELISA. Immobilized Recombinant Human ACE2 Protein at 2ug/mL (100 uL/well) can bind Recombinant SARS-COV-2 Spike RBD-mFc Protein. The EC50 of Recombinant SARS-COV-2 Spike RBD-mFc Protein is 2.58 ng/mL

Purity
> 95% by SDS-PAGE.

Endotoxin
< 0.1 EU/ug of the protein by LAL method.

Formulation
Lyophilized from a 0.22 um filtered solution of PBS, pH 7.4. or Supplied as a 0.22 um filtered solution in PBS, pH 7.4.4

Species
SARS-COV-2

Calculated MW
50.8kDa

Expressed Host
HEK293 cells

Tag
mFc tag at the C-terminus

Gene ID
43740568

Storage
Store the lyophilized protein at -20°C to -80°C for long term. After reconstitution, the protein solution is stable at -20°C for 3 months, at 2-8°C for up to 1 week. or This product is stable at ≤ -70°C for up to 6 months from the date of receipt. For optimal storage, aliquot into smaller quantities after centrifugation and store at the recommended temperature.

Reconstitution
For lyophilized protein: Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water.

Alternative Names
S1-RBD protein; NCP-CoV RBD Protein; novel coronavirus RBD Protein; 2019-nCoV RBD Protein; S glycoprotein Subunit1 RBD Protein; SARS-CoV-2; 2019-nCoV